Kohonen-Corish MRJ - Search Results

1

Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer.

Currey N, Jahan Z, Caldon CE, Tran PN, Benthani F, De Lacavalerie P, Roden DL, Gloss BS, Campos C, Bean EG, Bullman A, Reibe-Pal S, Dinger ME, Febbraio MA, Clarke SJ, Dahlstrom JE, Kohonen-Corish MRJ. Currey N, et al. Among authors: kohonen corish mrj. Cell Mol Gastroenterol Hepatol. 2019;7(4):819-839. doi: 10.1016/j.jcmgh.2019.01.009. Epub 2019 Mar 2. Cell Mol Gastroenterol Hepatol. 2019. PMID: 30831321 Free PMC article.

2

Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.

Kohonen-Corish MR, Daniel JJ, te Riele H, Buffinton GD, Dahlstrom JE. Kohonen-Corish MR, et al. Cancer Res. 2002 Apr 1;62(7):2092-7. Cancer Res. 2002. PMID: 11929830

3

Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer.

Kohonen-Corish MR, Sigglekow ND, Susanto J, Chapuis PH, Bokey EL, Dent OF, Chan C, Lin BP, Seng TJ, Laird PW, Young J, Leggett BA, Jass JR, Sutherland RL. Kohonen-Corish MR, et al. Oncogene. 2007 Jun 28;26(30):4435-41. doi: 10.1038/sj.onc.1210210. Epub 2007 Jan 29. Oncogene. 2007. PMID: 17260021

4

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma.

Seng TJ, Currey N, Cooper WA, Lee CS, Chan C, Horvath L, Sutherland RL, Kennedy C, McCaughan B, Kohonen-Corish MR. Seng TJ, et al. Br J Cancer. 2008 Jul 22;99(2):375-82. doi: 10.1038/sj.bjc.6604452. Epub 2008 Jul 1. Br J Cancer. 2008. PMID: 18594535 Free PMC article.

5

The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.

Mladenova D, Daniel JJ, Dahlstrom JE, Bean E, Gupta R, Pickford R, Currey N, Musgrove EA, Kohonen-Corish MR. Mladenova D, et al. Gut. 2011 Mar;60(3):350-60. doi: 10.1136/gut.2010.208314. Epub 2010 Oct 27. Gut. 2011. PMID: 20980345

6

Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.

Poursoltan P, Currey N, Pangon L, van Kralingen C, Selinger CI, Mahar A, Cooper WA, Kennedy CW, McCaughan BC, Trent R, Kohonen-Corish MR. Poursoltan P, et al. Lung Cancer. 2012 Aug;77(2):272-6. doi: 10.1016/j.lungcan.2012.04.001. Epub 2012 Apr 26. Lung Cancer. 2012. PMID: 22542170

7

Molecular pathways in colorectal cancer.

Al-Sohaily S, Biankin A, Leong R, Kohonen-Corish M, Warusavitarne J. Al-Sohaily S, et al. J Gastroenterol Hepatol. 2012 Sep;27(9):1423-31. doi: 10.1111/j.1440-1746.2012.07200.x. J Gastroenterol Hepatol. 2012. PMID: 22694276 Review.

8

Review: Mouse models of inflammatory bowel disease--insights into the mechanisms of inflammation-associated colorectal cancer.

Mladenova D, Kohonen-Corish MR. Mladenova D, et al. In Vivo. 2012 Jul-Aug;26(4):627-46. In Vivo. 2012. PMID: 22773577 Review.

9

Sulindac activates NF-κB signaling in colon cancer cells.

Mladenova D, Pangon L, Currey N, Ng I, Musgrove EA, Grey ST, Kohonen-Corish MR. Mladenova D, et al. Cell Commun Signal. 2013 Oct 1;11:73. doi: 10.1186/1478-811X-11-73. Cell Commun Signal. 2013. PMID: 24083678 Free PMC article.

10

KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.

Kohonen-Corish MR, Tseung J, Chan C, Currey N, Dent OF, Clarke S, Bokey L, Chapuis PH. Kohonen-Corish MR, et al. Int J Cancer. 2014 Jun 15;134(12):2820-8. doi: 10.1002/ijc.28619. Epub 2013 Dec 6. Int J Cancer. 2014. PMID: 24259266 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page